Jaromir Hirtenfeld

Recent publications · Crossref

5 total works indexed

1. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

   · 2019 · cited 2,788x

2. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

   · 2019 · cited 1,873x

3. American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy

   · 2003 · cited 1,216x

4. Rosuvastatin in Older Patients with Systolic Heart Failure

   · 2007 · cited 1,214x

5. Bisphenol A – Sources, toxicity and biotransformation

   · 2014 · cited 950x

via Crossref · CC0